Cargando…
Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure: A case report
RATIONALE: Tolvaptan (TLV) is a selective vasopressin type 2 receptor antagonist, which has an active effect on patients with congestive heart failure especially combined with hyponatremia. Increasingly, evidence has demonstrated that low-dose tolvaptan can dramatically relieve patients’ dyspnea and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635281/ https://www.ncbi.nlm.nih.gov/pubmed/31277136 http://dx.doi.org/10.1097/MD.0000000000016229 |